Table 2 Features of active cancers and association with in-hospital mortality in the study population
Type and stage of cancer | All patients with active cancer | Alive at hospital discharge | Deceased at hospital discharge | P-value |
|---|---|---|---|---|
Solid NADC | ||||
Overall (all types pooled) | 62 | 29 | 33 | |
Lung | 22 (35.5) | 11 (37.9) | 11 (33.3) | 0.09 |
Intestinal tract | 14 (22.6) | 4 (13.8) | 10 (30.4) | |
Upper aerodigestive tract | 7 (11.3) | 6 (20.7) | 1 (3.0) | |
Others | 19 (30.6) | 8 (27.6) | 11 (33.3) | |
Metastatic | 33 (53.2) | 14 (48.3) | 19 (57.6) | 0.81 |
Stage | ||||
Inaugural admission | 30 (48.3) | 14 (48.3) | 16 (48.5) | 0.97 |
Response | 16 (25.8) | 8 (27.6) | 8 (24.2) | |
Relapse | 4 (6.5) | 2 (6.9) | 2 (6.1) | |
Refractory | 12 (19.4) | 5 (17.2) | 7 (21.2) | |
Haematological NADC | ||||
Overall (all types pooled) | 35 | 24 | 11 | |
Hodgkin lymphoma | 10 (28.6) | 6 (25.0) | 4 (36.4) | 0.50 |
Non-AIDS-defining NHL a | 11 (31.4) | 7 (29.2) | 4 (36.4) | |
Acute leukaemia | 9 (25.7) | 8 (33.3) | 1 (9.1) | |
Myeloma | 5 (14.3) | 3 (12.5) | 2 (18.2) | |
Stage | ||||
Inaugural admission | 21 (60.0) | 15 (62.4) | 6 (54.5) | 0.48 |
Response | 9 (25.7) | 7 (29.2) | 2 (18.2) | |
Relapse | 3 (8.6) | 1 (4.2) | 2 (18.2) | |
Refractory | 2 (5.7) | 1 (4.2) | 1 (9.1) | |
Solid ADC | ||||
Overall (all types pooled) | 20 | 15 | 5 | NA |
Kaposi sarcoma | 19 (95.0) | 14 (93.3) | 5 (100) | |
Cervix cancer | 1 (5.0) | 1 (6.7) | 0 | |
Haematological ADC | ||||
Overall (all types pooled) | 86 | 59 | 27 | |
Primary cerebral NHL | 4 (4.6) | 3 (5.0) | 1 (3.7) | 0.04 |
Burkitt lymphoma | 35 (40.7) | 29 (49.2) | 6 (22.2) | |
Other AIDS-defining NHL b | 47 (54.7) | 27 (45.8) | 20 (74.1) | |
Stage | ||||
Inaugural admission | 65 (75.6) | 44 (74.5) | 21 (77.8) | 0.58 |
Response | 12 (14.0) | 10 (17.0) | 2 (7.4) | |
Relapse | 7 (8.1) | 4 (6.8) | 3 (11.1) | |
Refractory | 2 (2.3) | 1 (1.7) | 1 (3.7) | |